Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-05-07

Clinical Trial Update: Multiple Ascending Dose Trial of BYK324677 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 multiple ascending dose study of BYK324677 in healthy volunteers has completed. The study is associated with Type 2 Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BYK324677

Snippet

Sponsor: Nycomed | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED